TITLE

Determinants of adults' intention to vaccinate against pandemic swine flu

AUTHOR(S)
Myers, Lynn B.; Goodwin, Robin
PUB. DATE
January 2011
SOURCE
BMC Public Health;2011, Vol. 11 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Vaccination is one of the cornerstones of controlling an influenza pandemic. To optimise vaccination rates in the general population, ways of identifying determinants that influence decisions to have or not to have a vaccination need to be understood. Therefore, this study aimed to predict intention to have a swine influenza vaccination in an adult population in the UK. An extension of the Theory of Planned Behaviour provided the theoretical framework for the study. Methods: Three hundred and sixty two adults from the UK, who were not in vaccination priority groups, completed either an online (n = 306) or pen and paper (n = 56) questionnaire. Data were collected from 30th October 2009, just after swine flu vaccination became available in the UK, and concluded on 31st December 2009. The main outcome of interest was future swine flu vaccination intentions. Results: The extended Theory of Planned Behaviour predicted 60% of adults' intention to have a swine flu vaccination with attitude, subjective norm, perceived control, anticipating feelings of regret (the impact of missing a vaccination opportunity), intention to have a seasonal vaccine this year, one perceived barrier: "I cannot be bothered to get a swine flu vaccination" and two perceived benefits: "vaccination decreases my chance of getting swine flu or its complications" and "if I get vaccinated for swine flu, I will decrease the frequency of having to consult my doctor," being significant predictors of intention. Black British were less likely to intend to have a vaccination compared to Asian or White respondents. Conclusions: Theoretical frameworks which identify determinants that influence decisions to have a pandemic influenza vaccination are useful. The implications of this research are discussed with a view to maximising any future pandemic influenza vaccination uptake using theoretically-driven applications.
ACCESSION #
58027178

 

Related Articles

  • How the world threw away the chance to defeat a pandemic.  // New Scientist;5/2/2009, Vol. 202 Issue 2706, p3 

    The author reflects on the failure to organise the first line of defence, a vaccine, against the H1N1 pandemic. Measures such as washing a lot and cancelling public events can slow the spread of the virus. There are a few antiviral drugs, but without quick and accurate diagnosis they could be...

  • BATTLING H1N1. KEHOE, BOB // Health Facilities Management;Dec2009, Vol. 22 Issue 12, p12 

    The article provides an insider's perspective on the H1N1 flu pandemic and the many ripple effects caused by vaccine shortages. The earliest known and later confirmed case of H1N1 in the U.S. occurred in April 2009, when a 9-year-old girl in Imperial, California was struck by the virus. By April...

  • Effect of Vaccines and Antivirals during the Major 2009 A(H1N1) Pandemic Wave in Norway - And the Influence of Vaccination Timing. de Blasio, Birgitte Freiesleben; Iversen, Bj�rn G.; Tomba, Gianpaolo Scalia // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    To evaluate the impact of mass vaccination with adjuvanted vaccines (eventually 40% population coverage) and antivirals during the 2009 influenza pandemic in Norway, we fitted an age-structured SEIR model using data on vaccinations and sales of antivirals in 2009/10 in Norway to Norwegian ILI...

  • The Moment. Walsh, Bryan // Time International (Atlantic Edition);8/10/2009, Vol. 174 Issue 5, p7 

    The article discusses the H1N1/09 virus and the unpredictability of the number of deaths that the pandemic may cause in the U.S. and elsewhere when the weather gets colder. It notes the considerable adverse effects that have been realized in countries like Argentina where the winter season has...

  • Going Viral. Varchaver, Nicholas // Fortune International (Asia);9/28/2009, Vol. 160 Issue 5, p28 

    The article deals with the outbreaks of swine flu in the U.S. The President's Council of Advisors on Science and Technology predicts that about 150 million people in the U.S. could be infected by the swine flu virus. It relates the estimated number of doses of H1N1 vaccine that will be available...

  • Deaths and Hospitalizations Related to 2009 Pandemic Influenza A (H1N1) -- Greece, May 2009-February 2010. Efstathiou, P.; Tseroni, M.; Baka, A.; Manolidou, Z.; Karageorgou, K.; Sypsa, V.; Hatzakis, A. // MMWR: Morbidity & Mortality Weekly Report;6/11/2010, Vol. 59 Issue 22, p682 

    The article reports on cases of deaths and hospitalizations related to the 2009 pandemic influenza A H1N1 in Greece between May and February 2010. A surveillance was conducted by the Hellenic Centre for Diseases Control and Prevention (HCDCP) with the National Health Operations Centre (NaHOC) of...

  • Factors Affecting Intention to Receive and Self-Reported Receipt of 2009 Pandemic (H1N1) Vaccine in Hong Kong: A Longitudinal Study. Liao, Qiuyan; Cowling, Benjamin J.; Wendy Wing Tak Lam; Richard Fielding // PLoS ONE;2011, Vol. 6 Issue 3, p1 

    Background: Vaccination was a core component for mitigating the 2009 influenza pandemic (pH1N1). However, a vaccination program's efficacy largely depends on population compliance. We examined general population decisionmaking for pH1N1 vaccination using a modified Theory of Planned Behaviour...

  • Healthcare Worker Acceptance of Pandemic (H1N1) 2009 Vaccination, Morocco. Tagajdid, Rida; El Annaz, Hicham; Doblali, Taoufik; Sefiani, Kawtar; Belfquih, Bouchra; Mrani, Saad // Emerging Infectious Diseases;Oct2010, Vol. 16 Issue 10, p1638 

    A letter to the editor is presented about a survey of healthcare workers on the acceptance of pandemic H1N1 2009 vaccination in Morocco conducted from January 15 to February 28, 2010.

  • Effect of Vaccines and Antivirals during the Major 2009 A(H1N1) Pandemic Wave in Norway - And the Influence of Vaccination Timing. de Blasio, Birgitte Freiesleben; Iversen, Bjørn G.; Tomba, Gianpaolo Scalia // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    To evaluate the impact of mass vaccination with adjuvanted vaccines (eventually 40% population coverage) and antivirals during the 2009 influenza pandemic in Norway, we fitted an age-structured SEIR model using data on vaccinations and sales of antivirals in 2009/10 in Norway to Norwegian ILI...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics